Sales of Makena exceeded $1.4 billion from 2015 to 2019

Amounts in millions USD

A chart showing annual sales of the preterm birth drug Makena by Amag Pharmaceuticals.

(Please use a modern browser to see the interactive version of this visualization)

Chart: Ned Pagliarulo / BioPharma Dive Source: Amag Pharmaceuticals' filings